NCT05208944 2026-04-14THIO Sequenced With Cemiplimab in Advanced NSCLCMaia BiotechnologyPhase 2 Recruiting227 enrolled
NCT07446257 2026-03-03THIO and Cadonilimab in Resectable Hepatocellular CarcinomaUniversity of Texas Southwestern Medical CenterPhase EARLY_PHASE1 Not yet recruiting60 enrolled
NCT06908304 2026-01-12A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCMaia BiotechnologyPhase 3 Recruiting300 enrolled